Discover how a leading pharmaceutical company leveraged IQVIA's AI-powered solutions to optimize their pre-launch planning for a biologic treatment in the cardiovascular and metabolism market.

Situation and Challenge:

• The client needed detailed patient insights for the successful launch of their biologic treatment in a niche cardiovascular and metabolic market segment.
• They faced challenges in identifying subpopulations, sizing unmet medical needs, and quantifying the eligible population.

Solution:

• IQVIA deployed its AI-powered Patient Population and Journey and Physician Targeting solution, providing advanced patient and physician insights across markets.
• AI-modeling bridged data gaps and maximized the value of real-world data, enabling agile and competitive commercialization efforts through dynamic analysis of treatments, patient profiling, and physician-related insights.

Key Benefits:

• Identified 2x-5x more eligible patients for the biologic treatment.
• Re-clustered 30% of treating physicians for precise segmentation.
• Optimized forecasting model and refined physician segmentation and outreach strategy.